Braidwell LP
- SEC CIK
- 0001920938
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 88
- +15 vs. Q4 2025
- Portfolio value
- $3.00B
- −$129.3M (−4.1%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CAICaris Life Sciences, Inc. | COM | 8,009,447 | $143.2M | 4.8% | +193,305+2.5% | Added | History |
| Guardant Health, Inc.40131MAD1 | DEBT 1.250% 2/1 | – | $102.6M | 3.4% | – | – | – |
| Repligen Corp759916AD1 | NOTE 1.000%12/1 | – | $98.7M | 3.3% | – | – | – |
| Neogenomics Inc64049MAB6 | NOTE 0.250% 1/1 | – | $91.8M | 3.1% | – | – | – |
| NBIXNeurocrine Biosciences Inc | Stock | 652,121 | $85.9M | 2.9% | −99,413−13.2% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 763,505 | $82.2M | 2.7% | −158,474−17.2% | Reduced | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,986,768 | $78.9M | 2.6% | −201,552−9.2% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,338,452 | $77.8M | 2.6% | −486,624−26.7% | Reduced | History |
| DNTHDianthus Therapeutics, Inc. | COM | 899,364 | $75.5M | 2.5% | −374,571−29.4% | Reduced | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 2,347,583 | $73.9M | 2.5% | −2,863,248−54.9% | Reduced | History |
| IRTCiRhythm Holdings, Inc. | COM | 610,192 | $72.0M | 2.4% | +392,847+180.7% | Added | History |
| NUVLNuvalent, Inc. | COM | 700,429 | $71.8M | 2.4% | −120,977−14.7% | Reduced | History |
| KODKodiak Sciences Inc. | COM | 1,818,665 | $69.3M | 2.3% | −254,123−12.3% | Reduced | History |
| CGONCG Oncology, Inc. | COM | 984,783 | $66.7M | 2.2% | −885,788−47.4% | Reduced | History |
| Alphatec Hldgs Inc02081GAD4 | NOTE 0.750% 3/1 | – | $63.4M | 2.1% | – | New | – |
| ARGXArgenx SE | SPONSORED ADR | 84,939 | $62.0M | 2.1% | +53,932+173.9% | Added | History |
| HNGEHinge Health, Inc. | CL A | 1,455,123 | $56.1M | 1.9% | +150,500+11.5% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 2,471,199 | $55.0M | 1.8% | +439,178+21.6% | Added | History |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 3,206,574 | $52.7M | 1.8% | +2,258,258+238.1% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 182,425 | $47.1M | 1.6% | −19,676−9.7% | Reduced | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 932,823 | $47.1M | 1.6% | −701,792−42.9% | Reduced | History |
| GHGuardant Health, Inc. | COM | 499,712 | $46.2M | 1.5% | +499,712 | New | History |
| TMOThermo Fisher Scientific Inc. | Stock | 92,915 | $45.7M | 1.5% | +12,190+15.1% | Added | History |
| GENBGenerate Biomedicines, Inc. | COM SHS | 3,592,999 | $44.9M | 1.5% | +3,592,999 | New | History |
| MBXMBX Biosciences, Inc. | COM | 1,492,467 | $44.6M | 1.5% | +473,867+46.5% | Added | History |
| BTSGBrightSpring Health Services, Inc. | COM | 1,016,562 | $43.3M | 1.4% | −179,224−15.0% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,356,082 | $43.0M | 1.4% | −502,027−27.0% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 5,617,402 | $41.7M | 1.4% | +984,601+21.3% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 478,667 | $40.3M | 1.3% | −96,400−16.8% | Reduced | History |
| DRUGBright Minds Biosciences Inc. | COM NEW | 539,708 | $39.4M | 1.3% | +215,350+66.4% | Added | History |
| CDNACareDx, Inc. | COM | 2,173,146 | $37.7M | 1.3% | +587,926+37.1% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 77,297 | $35.6M | 1.2% | −6,120−7.3% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 677,570 | $34.9M | 1.2% | +136,680+25.3% | Added | History |
| PENPenumbra Inc | COM | 105,352 | $34.6M | 1.2% | −4,800−4.4% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 329,391 | $32.7M | 1.1% | +14,050+4.5% | Added | History |
| SLNOSoleno Therapeutics Inc | COM | 959,259 | $32.1M | 1.1% | −228,600−19.2% | Reduced | History |
| DYNDyne Therapeutics, Inc. | COM | 1,681,998 | $30.5M | 1.0% | +203,669+13.8% | Added | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 10,240,164 | $29.0M | 1.0% | +1,886,877+22.6% | Added | History |
| ILMNIllumina, Inc. | COM | 229,215 | $28.3M | 0.9% | −40,458−15.0% | Reduced | History |
| KYMRKymera Therapeutics, Inc. | COM | 337,559 | $28.1M | 0.9% | −116,700−25.7% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 497,020 | $28.1M | 0.9% | −104,500−17.4% | Reduced | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,750,766 | $27.1M | 0.9% | −433,098−19.8% | Reduced | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 310,628 | $27.0M | 0.9% | +310,628 | New | History |
| DHRDanaher Corp | Stock | 139,327 | $26.4M | 0.9% | +21,100+17.8% | Added | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 463,600 | $26.3M | 0.9% | +463,600 | New | History |
| TECXTectonic Therapeutic, Inc. | COM | 847,151 | $26.2M | 0.9% | −80,373−8.7% | Reduced | History |
| NTRANatera, Inc. | COM | 129,000 | $25.8M | 0.9% | +17,500+15.7% | Added | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 1,752,798 | $25.6M | 0.9% | +1,752,798 | New | History |
| FULCFulcrum Therapeutics, Inc. | COM | 3,134,922 | $24.0M | 0.8% | +73,700+2.4% | Added | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 3,988,989 | $23.7M | 0.8% | +808,600+25.4% | Added | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 2,172,725 | $23.6M | 0.8% | +2,172,725 | New | History |
| DMRADamora Therapeutics, Inc. | COM NEW | 894,846 | $23.2M | 0.8% | +894,846 | New | History |
| BSXBoston Scientific Corp | Stock | 346,467 | $21.7M | 0.7% | +346,467 | New | History |
| VERAVera Therapeutics, Inc. | CL A | 523,824 | $21.1M | 0.7% | −260,918−33.2% | Reduced | History |
| BIOABioAge Labs, Inc. | COM | 1,200,587 | $21.0M | 0.7% | +1,200,587 | New | History |
| CVSCVS Health Corp | Stock | 290,700 | $20.9M | 0.7% | −273,500−48.5% | Reduced | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 265,715 | $18.6M | 0.6% | +265,715 | New | History |
| ELVElevance Health, Inc. | Stock | 62,080 | $18.2M | 0.6% | +62,080 | New | History |
| KIDSOrthopediatrics Corp | COM | 1,100,370 | $17.5M | 0.6% | 00.0% | Unchanged | History |
| ENGNenGene Therapeutics Inc. | COM | 2,456,870 | $16.7M | 0.6% | −674,449−21.5% | Reduced | History |
| NKTRNektar Therapeutics | COM NEW | 222,701 | $16.0M | 0.5% | +222,701 | New | History |
| ACHCAcadia Healthcare Company, Inc. | COM | 645,900 | $15.1M | 0.5% | +645,900 | New | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,128,040 | $14.3M | 0.5% | +1,128,040 | New | History |
| AVAHAveanna Healthcare Holdings, Inc. | COM | 2,203,506 | $14.2M | 0.5% | +2,203,506 | New | History |
| XFORX4 Pharmaceuticals, Inc | COM NEW | 3,272,954 | $13.5M | 0.5% | −95,950−2.8% | Reduced | History |
| Zenas BioPharma, Inc.98937LAA3 | NOTE 2.500% 4/0 | – | $13.5M | 0.4% | – | New | – |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 272,522 | $13.1M | 0.4% | −41,301−13.2% | Reduced | History |
| EOLSEvolus, Inc. | COM | 3,105,209 | $12.8M | 0.4% | 00.0% | Unchanged | History |
| TGTXTG Therapeutics, Inc. | COM | 358,800 | $11.9M | 0.4% | +358,800 | New | History |
| SRZNSurrozen, Inc. | COM NEW | 396,100 | $11.5M | 0.4% | −73,900−15.7% | Reduced | History |
| CNCCentene Corp | Stock | 330,000 | $10.8M | 0.4% | +330,000 | New | History |
| CLYMClimb Bio, Inc. | COM | 1,529,675 | $10.5M | 0.3% | +1,529,675 | New | History |
| CMPXCompass Therapeutics, Inc. | COM | 1,965,106 | $10.4M | 0.3% | −821,672−29.5% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 130,862 | $9.83M | 0.3% | +130,862 | New | History |
| HLXCHelix Acquisition Corp. III | USD CL A ORD SHS | 900,000 | $9.27M | 0.3% | +900,000 | New | History |
| VORVor Biopharma Inc. | COM NEW | 466,774 | $8.33M | 0.3% | +466,774 | New | History |
| RVMDRevolution Medicines, Inc. | COM | 84,900 | $8.26M | 0.3% | +84,900 | New | History |
| GRALGRAIL, Inc. | COM | 142,755 | $7.38M | 0.2% | 00.0% | Unchanged | History |
| ACRSAclaris Therapeutics, Inc. | COM | 1,699,116 | $6.37M | 0.2% | +1,699,116 | New | History |
| DNLIDenali Therapeutics Inc. | COM | 296,324 | $5.69M | 0.2% | +296,324 | New | History |
| RGENRepligen Corp | COM | 47,500 | $5.60M | 0.2% | −34,290−41.9% | Reduced | History |
| HROWHarrow, Inc. | COM | 156,419 | $5.52M | 0.2% | −138,872−47.0% | Reduced | History |
| RVTYRevvity, Inc. | COM | 48,400 | $4.24M | 0.1% | +48,400 | New | History |
| CELCCelcuity Inc. | COM | 29,198 | $3.33M | 0.1% | +29,198 | New | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 9,976 | $3.21M | 0.1% | +9,976 | New | History |
| Arrowhead Pharmaceuticals IN04280AAC4 | NOTE 1/1 | – | $2.33M | 0.1% | – | New | – |
| LUNGPulmonx Corp | COM | 752,541 | $970.8K | <0.1% | 00.0% | Unchanged | History |
| YARWYarrow Bioscience, Inc. | COM | 916,077 | $547.4K | <0.1% | +916,077 | New | History |
Sold out since Q4 2025 (16)
Positions held at the end of Q4 2025 that are gone from this filing.
| Security | Class | Shares in Q4 2025 | Value in Q4 2025 | % of portfolio in Q4 2025 | History |
|---|---|---|---|---|---|
| iRhythm Holdings, Inc.450056AB2 | NOTE 1.500% 9/0 | – | $72.8M | 2.3% | – |
| ALGNAlign Technology Inc | COM | 381,004 | $59.5M | 1.9% | History |
| Ironwood Pharmaceuticals Inc46333XAH1 | NOTE 1.500% 6/1 | – | $50.5M | 1.6% | – |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 929,694 | $31.5M | 1.0% | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,298,142 | $28.2M | 0.9% | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 575,321 | $23.2M | 0.7% | History |
| BIIBBiogen Inc. | COM | 115,700 | $20.4M | 0.7% | History |
| VTYXVentyx Biosciences, Inc. | COM | 1,920,255 | $17.3M | 0.6% | History |
| ICLRIcon PLC | COM | 73,370 | $13.4M | 0.4% | History |
| RLMDRelmada Therapeutics, Inc. | COM | 1,582,257 | $7.64M | 0.2% | History |
| XNCRXencor Inc | COM | 459,166 | $7.03M | 0.2% | History |
| CSTLCastle Biosciences Inc | COM | 177,183 | $6.89M | 0.2% | History |
| ADPTAdaptive Biotechnologies Corp | COM | 311,991 | $5.07M | 0.2% | History |
| BLLNBillionToOne, Inc. | CL A | 50,000 | $4.09M | 0.1% | History |
| ORKAOruka Therapeutics, Inc. | COM | 84,795 | $2.57M | 0.1% | History |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 303,370 | $2.23M | 0.1% | History |